Full Breakdown
UK Faces Imminent Medicine Shortages Due to Ongoing Iran Conflict
3/28/2026, 1:09:09 PM
Current Situation and Impending Shortages
Experts warn that the United Kingdom is “a few weeks away” from potential medicine shortages if the ongoing conflict in Iran persists. The war has disrupted the supply chain for essential health products, affecting medications ranging from painkillers to cancer treatments. David Weeks, the director of supply chain risk management at Moody’s, described the situation as a “perfect storm,” exacerbated by the near-total closure of the Strait of Hormuz, a critical shipping route for pharmaceuticals. The UK relies heavily on imports for its medications, with approximately one-third sourced from India, which is known for producing a significant portion of the world’s generic drugs and active pharmaceutical ingredients (APIs).
Supply Chain Disruptions
The conflict has led to significant disruptions in both air and sea shipments. With major airports in the Gulf region initially closed and now operating on a limited schedule, pharmaceutical companies have been forced to reroute shipments, increasing delivery times. Air cargo levels in the region have dropped by 80%, severely impacting the transport of time-sensitive medications, including cancer treatments and biologics that require cold storage. Frank Van Gelder, a supply chain strategist, noted that while healthcare cargo is prioritized, the overall disruption has raised transport costs significantly, with air freight costs doubling due to the conflict.
Economic Implications
The rising costs associated with transportation and raw materials, including oil and gas, are expected to lead to price increases for medications. Mark Samuels, chief executive of Medicines UK, indicated that while the UK is not currently in a crisis, prolonged disruptions could deplete existing stockpiles, which typically last six to eight weeks. Suppliers, facing historically low margins, may find some medications unprofitable to supply to the National Health Service (NHS), leading to potential price hikes, particularly for general practitioners and pharmacies.
Criticism and Concerns
Critics express concern over the financial burden that rising medication prices will place on patients and public health systems. Wouter Dewulf, a professor at the Antwerp Management School, emphasized that while supplies are currently “not disrupted, but disturbed,” the longer the conflict lasts, the more likely drug manufacturers will pass increased costs onto consumers. The implications for the healthcare system could be significant, with patients ultimately bearing the financial burden.
Verbatim Quotes
- “David Weeks, the Texas-based director of supply chain risk management at the analytics group Moody’s, said: “It’s the perfect storm.” — David Weeks, Director of Supply Chain Risk Management, Moody’s
- “We’re not in a crisis currently but it’s still a serious situation,” — Mark Samuels, Chief Executive, Medicines UK
- “So in the end we all pay more, right?” — Unattributed
Conclusion
The ongoing conflict in Iran poses a serious threat to the UK's pharmaceutical supply chain, with experts warning of imminent medicine shortages and rising costs. As the situation evolves, the healthcare system and patients may face significant challenges in accessing essential medications.
